fludeoxyglucose (18f)/ge healthcare inj.sol 250mbq/ml
ge healthcare b.v., the netherlands de rondom 8, 5612 ap eindhoven - fludeoxyglucose (18f) - inj.sol (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 250mbq/ml - fludeoxyglucose (18f) 250mbq - fludeoxyglucose (18f)
drytec, radionuklīdu ģenerators
ge healthcare b.v, netherlands - natrii molybdas (99mo), natrii pertechnetas (99mtc) - radionuklīdu ģenerators
omnipaque 350 mg i/ml šķīdums injekcijām
ge healthcare b.v, netherlands - joheksols - Šķīdums injekcijām - 755 mg/ml
visipaque 270 mg i/ml šķīdums injekcijām
ge healthcare b.v, netherlands - jodiksanols - Šķīdums injekcijām - 550 mg/ml
visipaque 320 mg i/ml šķīdums injekcijām
ge healthcare b.v, netherlands - jodiksanols - Šķīdums injekcijām - 652 mg/ml
sodium iodide [123i] capsules ge healthcare -
ge healthcare b.v. - natriumjodid (123i) - kapsel, hard
sodium iodide [123i] injection ge healthcare 37 mbq/ ml
ge healthcare b.v. - natriumjodid (123i) - injeksjonsvæske, oppløsning - 37 mbq/ ml
drytec radionuclide generator
ge healthcare pte. ltd. - sodium molybdate (99mo); sodium pertechnetate (99mtc) - injection - 2.5-100 gbq/generator - sodium molybdate (99mo) 2.5-100 gbq/generator; sodium pertechnetate (99mtc) variable
datscan
ge healthcare b.v. - ioflupane (123l) - tomography, emission-computed, single-photon; lewy body disease; parkinson disease; alzheimer disease - diagnostic radiopharmaceuticals - this medicinal product is for diagnostic use only.datscan is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum:in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson’s disease, multiple system atrophy and progressive supranuclear palsy. datscan is unable to discriminate between parkinson's disease, multiple system atrophy and progressive supranuclear palsy.in adult patients, to help differentiate probable dementia with lewy bodies from alzheimer’s disease. datscan is unable to discriminate between dementia with lewy bodies and parkinson’s disease dementia.
ge discovery mr750 3.0t magnetic resonance imaging system
ge healthcare pte. ltd. - radiology / imaging - the ge discovery mr750 3.0t system is a whole body magnetic resonance scanner indicated for use as a diagnostic imaging device to produce axial, sagittal, coronal, and oblique images, spectroscopic images, parametric maps, and/or spectra, dynamic images of the structures and organs of the entire body, including, but not limited to, head, neck, tmj, spine, breast, heart, abdomen, pelvis, joints, prostate, blood vessels, and musculoskeletal regions of the body. depending on the region of interest being imaged, contrast agents may be used. the images produced by the system reflect the spatial distribution or molecular environment of nuclei exhibiting magnetic resonance. these images when interpreted by a trained physician yield information that may assist in diagnosis.